title: Usefulness of immunoadsorption therapy for systemic lupus erythematosus associated with transverse myelitis. A case report.
abstract: Transverse myelitis (TM) is a very rare complication of systemic lupus erythematosus (SLE) and its prognosis is poor. It therefore needs to be treated aggressively. We describe a patient suffering from SLE associated with TM, who responded well to a combination of immunoadsorption therapy and steroid mini-pulse therapy. His serum interleukin 6 levels as well as clinical indicators fell to normal after this treatment.
authors.affiliation: Second Department of Internal Medicine, Hiroshima University School of Medicine, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Taniguchi
authors.forename: N
authors.initials: N
authors.lastname: Yorioka
authors.forename: S
authors.initials: S
authors.lastname: Okushin
authors.forename: H
authors.initials: H
authors.lastname: Oda
authors.forename: K
authors.initials: K
authors.lastname: Usui
authors.forename: M
authors.initials: M
authors.lastname: Yamakido
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001798:Blood Proteins / Q000378:metabolism; D006801:Humans; D007163:Immunosorbent Techniques; D007164:Immunosorbents / Q000627:therapeutic use*; D015850:Interleukin-6 / Q000378:metabolism*; D007564:Japan; D008180:Lupus Erythematosus, Systemic / Q000503:physiopathology*; D008297:Male; D009188:Myelitis, Transverse / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D010649:Phenylalanine / Q000627:therapeutic use; D013256:Steroids; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D007164:Immunosorbents; D015850:Interleukin-6; D013256:Steroids; D010649:Phenylalanine